103 related articles for article (PubMed ID: 22798124)
1. A case of primary gastric Burkitt-like lymphoma with chemotherapy-induced perforation.
Ergün M; Cindoruk M; Akyürek N; Akyol G; Ünal S
Turk J Gastroenterol; 2012 Jun; 23(3):299-300. PubMed ID: 22798124
[No Abstract] [Full Text] [Related]
2. A rare cause of gastric malignancy: Burkitt's lymphoma.
Doycheva I; Tanner S; Zhou D; Samadder NJ
Endoscopy; 2013; 45 Suppl 2 UCTN():E432-3. PubMed ID: 24338176
[No Abstract] [Full Text] [Related]
3. Delayed-onset and long-lasting severe neutropenia due to rituximab.
Hofer S; Viollier R; Ludwig C
Swiss Med Wkly; 2004 Feb; 134(5-6):79-80. PubMed ID: 15113056
[TBL] [Abstract][Full Text] [Related]
4. [Primary gastric lesion in Berkitt-like lymphoma].
Zvonkov EE; Boriakh EA; Magomedova AU; Kravchenko SK; Kremenetskaia AM; Obukhova TN; Kaplanskaia IB; Samoĭlova RS; Makhinia VA; Shavlokhov VS; Krasil'nikova BB; Egorova EK; Danishian KI
Ter Arkh; 2005; 77(7):85-8. PubMed ID: 16116918
[No Abstract] [Full Text] [Related]
5. Clinical outcomes of AIDS-related Burkitt lymphoma: a multi-institution retrospective survey in Japan.
Kojima Y; Hagiwara S; Uehira T; Ajisawa A; Kitanaka A; Tanuma J; Okada S; Nagai H
Jpn J Clin Oncol; 2014 Apr; 44(4):318-23. PubMed ID: 24558129
[TBL] [Abstract][Full Text] [Related]
6. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
[TBL] [Abstract][Full Text] [Related]
7. [Risk of reactivation of hepatitis B in patients with the lymphoma HBsAg negative , anti-HBc positive treated with rituximab-CHOP].
Pariente A
Rev Prat; 2014 Mar; 64(3):324. PubMed ID: 24851363
[No Abstract] [Full Text] [Related]
8. Burkitt lymphoma of the stomach in an immunocompetent patient.
Dorra T; Norsaf B; Meriam S; Asma O; Ehsen BB
Gastrointest Endosc; 2018 Nov; 88(5):880-881. PubMed ID: 30036508
[No Abstract] [Full Text] [Related]
9. HBV reactivation in immunosuppressed patients: prevention or containment?
Ludwig E
Hepatology; 2014 Jun; 59(6):2062-4. PubMed ID: 24753022
[No Abstract] [Full Text] [Related]
10. A rapidly growing lymphoma and tumor lysis syndrome in a toddler.
Green HL; Rytting ME; Cox CS
JAAPA; 2010 Aug; 23(8):30, 32-4. PubMed ID: 20821911
[No Abstract] [Full Text] [Related]
11. Phase 3 study of frontline rituximab, cyclophosphamide, doxorubicin, and prednisone plus vincristine (R-CHOP) or bortezomib (VR-CAP) in transplantation-unsuitable mantle cell lymphoma (MCL) patients.
Clin Adv Hematol Oncol; 2014 Aug; 12(8 Suppl 16):9-11. PubMed ID: 25768994
[No Abstract] [Full Text] [Related]
12. Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectiveness.
Hay AE; Meyer RM
J Clin Oncol; 2012 Sep; 30(26):3155-7. PubMed ID: 22891267
[No Abstract] [Full Text] [Related]
13. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.
Chiappella A; Martelli M; Angelucci E; Brusamolino E; Evangelista A; Carella AM; Stelitano C; Rossi G; Balzarotti M; Merli F; Gaidano G; Pavone V; Rigacci L; Zaja F; D'Arco A; Cascavilla N; Russo E; Castellino A; Gotti M; Congiu AG; Cabras MG; Tucci A; Agostinelli C; Ciccone G; Pileri SA; Vitolo U
Lancet Oncol; 2017 Aug; 18(8):1076-1088. PubMed ID: 28668386
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus retinitis during chemotherapy with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone.
Libby E; Movva S; Quintana D; Abdul-Jaleel M; Das A
J Clin Oncol; 2010 Nov; 28(32):e661-2. PubMed ID: 20855824
[No Abstract] [Full Text] [Related]
15. Rituximab in combination with multiagent chemotherapy for pediatric follicular lymphoma.
Kumar R; Galardy PJ; Dogan A; Rodriguez V; Khan SP
Pediatr Blood Cancer; 2011 Aug; 57(2):317-20. PubMed ID: 21462303
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism at
Bashash M; Connors JM; Gascoyne RD; Meissner B; Schuetz JM; Leach S; Slack GW; Berry BR; Hu H; Sehn LH; Brooks-Wilson AR; Spinelli JJ
Haematologica; 2017 May; 102(5):e199-e202. PubMed ID: 28154089
[No Abstract] [Full Text] [Related]
17. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
Kato H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
[No Abstract] [Full Text] [Related]
18. [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].
Maruyama D
Rinsho Ketsueki; 2011 Oct; 52(10):1645-54. PubMed ID: 21971242
[No Abstract] [Full Text] [Related]
19. Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma.
Musolino A; Boggiani D; Panebianco M; Vasini G; Salvagni S; Franciosi V; Ardizzoni A
Cancer; 2011 Mar; 117(5):964-73. PubMed ID: 20960528
[TBL] [Abstract][Full Text] [Related]
20. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
Johnston KL; Farnen JP; Manske BR; Go RS
Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
